Enzon Pharmaceuticals (ENZN)

3.17 -0.01  -0.31%  May 17, 8:00PM
Add to Watchlists Create an Alert

Enzon Pharmaceuticals Current Ratio:

1.624 for Dec. 31, 2012
View Full Chart

Enzon Pharmaceuticals Current Ratio Chart

    Enzon Pharmaceuticals Historical Current Ratio Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 3   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 1.624
    Sept. 30, 2012 2.258
    June 30, 2012 1.059
    March 31, 2012 9.803
    Dec. 31, 2011 10.83
    Sept. 30, 2011 22.56
    June 30, 2011 29.10
    March 31, 2011 28.23
    Dec. 31, 2010 23.64
    Sept. 30, 2010 17.14
    June 30, 2010 17.06
    March 31, 2010 16.17
    Dec. 31, 2009 5.809
    Sept. 30, 2009 5.057
    June 30, 2009 5.924
    March 31, 2009 6.465
    Dec. 31, 2008 4.916
    Sept. 30, 2008 4.810
    June 30, 2008 3.918
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro
    June 30, 2000 Go Pro

    About Current Ratio

    The current ratio measures a company's ability to pay short-term debts and other current liabilities (financial obligations lasting less than one year) by comparing current assets to current liabilities. The ratio illustrates a company's ability to remain solvent.

    A current ratio of one means that book value of current assets is exactly the same as book value of current liabilities. In general, investors look for a company with a current ratio of 2:1, meaning current assets twice as large as current liabilities. A current ratio less than one indicates the company might have problems meeting short-term financial obligations. If the ratio is too high, the company may not be efficiently using its current assets or short term financing facilities.

    Other similar solvency ratios include :
    Cash Ratio - Measures the amount of cash that can be used to pay liabilities (most strict)
    Quick Ratio - Measures the amount of cash, short term equivalents, and accounts receivables that can be used to pay liabilities (more lenient than cash ratio, but stricter than current ratio)
    Learn More

    Get data for

    ENZN Current Ratio Benchmarks

    Companies
    AVEO Pharmaceuticals 4.029
    Santarus 2.394
    Idenix Pharmaceuticals 9.680

    ENZN Current Ratio Rankings

    Overall 63rd percentile
    2757 of 7593
    Sector 28th percentile
    466 of 650 in Healthcare
    Industry 21st percentile
    187 of 237 in Biotechnology

    ENZN Current Ratio Range, Past 5 Years

    Minimum 1.059 Jun 2012
    Maximum 29.10 Jun 2011
    Average 11.39